Google
Trusted Resources: Community Center
Online support, community stories, financial assistance
To Live a Sparkly Life
It’s been a couple of months now, and I’m pleased to say I am tolerating the new drug, Carfilzomib, brand name Kyprolis, very well. I’m now on the ‘Dara’ (Daratumumab AKA Darzolex) just once a month, but I’m getting the Kyprolis 6 times every three weeks, so I am getting to know my nurses very well! The Kyprolis visits are relatively short, lasting an hour to 2 hours each time, depending on whether we are doing lab work, etc.
On the Dara day each month, the Kyprolis adds another 10 minutes onto the 5 hour visit. The Dara days are the nap days. I’m still getting nothing done, but it is incredibly relaxing as the Benedryl takes hold and I’m off to a delicious dreamland for an hour or two or three.
Source: https://toliveasparklylife.com/
myBinderRelated Content
-
Update on CAEL101 Anti-fibril Agent: Michael Spector – ASG Webinar 6/13https://www.youtube.com/watch?v=NrEjyVeJ...
-
Managing hATTR Amyloidosishttps://www.youtube.com/watch?v=mlEYOijR...
-
Organ Involvement in AL Amyloidosishttps://www.youtube.com/watch?v=CEv7X2Rw...
-
Q&A Session 2: More Answers to Patient Questions About AL Amyloidosishttps://www.youtube.com/watch?v=ZLUHc-sJ...
-
He Inherited A Devastating Disease. A CRISPR Gene-Editing Breakthrough Stopped ItPatrick Doherty had always been very act...
-
Diarrhea and AL AmyloidosisDiarrhoea is the passing of loose or wat...
-
University of Maryland Medical CenterUniversity of Maryland Medical Center is...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
